Adults seeking professional help with weight management may consider the service when lifestyle measures alone have not provided sufficient progress
In those with Type 2 diabetes, semaglutide was shown to reduce cardiovascular risk, both for those who were high-risk and low-risk for CVD
The most effective balance of GLP-1, GIP, and glucagon activity may differ by patient phenotype, diabetes status, degree of obesity, hepatic steatosis, baseline insulin resistance, and tolerability profile
Add 2 mL, you get 5 mg/mL
The costs are actually incurred now, whereas the savings can only be realized in the distant future and then not with any certainty
As a result, potential safety concerns might arise in everyday clinical practice that were not evident during the more controlled and structured environment of clinical trial evaluations [Reference Paludetto, Olivier-Abbal and Montastruc28]